Compartive Study Between Caudal and Perianal Block During Anal Sphincter Sparing Procedures Under General Anesthesia
Launched by CAIRO UNIVERSITY · Sep 24, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two types of pain relief methods during surgery for a condition called anal fistula, which is an abnormal connection between the skin around the anus and the anal canal. The researchers want to compare the effectiveness of two regional anesthesia techniques—caudal block and perianal block—when combined with general anesthesia. The goal is to see which method provides better pain control after surgery and helps maintain muscle tone in the anal area.
To participate in the trial, individuals must be between 18 and 60 years old and have a complex anal fistula. However, there are some exclusions, such as those with allergies to certain local anesthetics or specific health conditions that would make these procedures unsafe. If eligible, participants can expect to receive one of the two pain relief methods during their surgery and will be monitored for their pain and recovery afterward. This study aims to improve postoperative care and outcomes for patients undergoing sphincter-sparing surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-60 years old patients
- • ASA I-IIIpatients
- • Patients with complex anal fistula
- Exclusion Criteria:
- • known hypersensitivity to amide type local anesthetics
- • Patients with contraindications to caudal block or perianal block: use of anticoagulant medication, local infection in the intervention site, increased intracranial pressure and severe aortic and / or mitral valve stenosis.
- • Patients who do not accept regional anesthesia
- • BMI (Body mass index) \> 35 kg/m2
- • Anatomical abnormalities and previous surgeries involving the sacrum
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Osama M Assad, professor
Principal Investigator
Anesthesia department , cairo university
Amany H Saleh, assprofessor
Study Director
Anesthesia department , Cairo university
Mona H Elsherbiny, lecturer
Study Chair
Anesthesia department , cairo university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials